Correlation Between Federated Short-intermedia and Pharmaceuticals Ultrasector
Can any of the company-specific risk be diversified away by investing in both Federated Short-intermedia and Pharmaceuticals Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Federated Short-intermedia and Pharmaceuticals Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Federated Short Intermediate Duration and Pharmaceuticals Ultrasector Profund, you can compare the effects of market volatilities on Federated Short-intermedia and Pharmaceuticals Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Federated Short-intermedia with a short position of Pharmaceuticals Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Federated Short-intermedia and Pharmaceuticals Ultrasector.
Diversification Opportunities for Federated Short-intermedia and Pharmaceuticals Ultrasector
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Federated and Pharmaceuticals is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Federated Short Intermediate D and Pharmaceuticals Ultrasector Pr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmaceuticals Ultrasector and Federated Short-intermedia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Federated Short Intermediate Duration are associated (or correlated) with Pharmaceuticals Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmaceuticals Ultrasector has no effect on the direction of Federated Short-intermedia i.e., Federated Short-intermedia and Pharmaceuticals Ultrasector go up and down completely randomly.
Pair Corralation between Federated Short-intermedia and Pharmaceuticals Ultrasector
Assuming the 90 days horizon Federated Short Intermediate Duration is expected to generate 0.08 times more return on investment than Pharmaceuticals Ultrasector. However, Federated Short Intermediate Duration is 12.69 times less risky than Pharmaceuticals Ultrasector. It trades about 0.23 of its potential returns per unit of risk. Pharmaceuticals Ultrasector Profund is currently generating about -0.16 per unit of risk. If you would invest 996.00 in Federated Short Intermediate Duration on November 27, 2024 and sell it today you would earn a total of 5.00 from holding Federated Short Intermediate Duration or generate 0.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Federated Short Intermediate D vs. Pharmaceuticals Ultrasector Pr
Performance |
| Timeline |
| Federated Short-intermedia |
| Pharmaceuticals Ultrasector |
Federated Short-intermedia and Pharmaceuticals Ultrasector Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Federated Short-intermedia and Pharmaceuticals Ultrasector
The main advantage of trading using opposite Federated Short-intermedia and Pharmaceuticals Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Federated Short-intermedia position performs unexpectedly, Pharmaceuticals Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmaceuticals Ultrasector will offset losses from the drop in Pharmaceuticals Ultrasector's long position.The idea behind Federated Short Intermediate Duration and Pharmaceuticals Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Pharmaceuticals Ultrasector vs. Iaadx | Pharmaceuticals Ultrasector vs. Flkypx | Pharmaceuticals Ultrasector vs. Ffcdax | Pharmaceuticals Ultrasector vs. Aam Select Income |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |